Cath Lab Recap: Abbott ICDs in Trouble; TAVR Sans Balloon Predilation Interventional cardiology news to note
The FDA warned Abbott Laboratories that several of its implantable cardioverter defibrillators (acquired with the purchase of St. Jude Medical) had serious manufacturing flaws that the firm had not reported, including prematurely draining lithium batteries. (Reuters)